Ebola quarantine hindering response: aid workers - National - Global News

Earlier this year, zombie checkpoint simulator Quarantine Zone took the world by storm. Millions of you stepped up to protect this undead-ravaged outpost at the end of the world, screening survivors, weeding out the infected, and uncovering the mystery of the outbreak. But it’s been a while, right? You’ve probably moved on, hung up your scanner, and forgotten all about Georgie and all the other brave souls protecting the last remnants of humanity. But it’s time to go back. Way back. Miami Zero is a massive free expansion that transports you to the sun-soaked (and frequently rain-soaked) streets of Miami, back to when the virus was first unleashed on the world. This was ground zero for the outbreak and in this DLC you’ll find yourself right in the thick of it, screening desperate survivors, identifying symptoms, and making tough calls about who lives and who dies. The fate of the world rests on your shoulders, and your scanner, but hey – at least the sun is shining!

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.